NCT02225548: A trial that was reported late by University of South Florida
This trial has reported, although it was 675 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02225548 |
|---|---|
| Title | An Open-label Trial of Oral Selegiline 5 or 10 mg and Tadalafil 2.5mg Co-administration to Male Patients With Parkinson's Disease and Moderate Erectile Dysfunction. |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Sept. 30, 2014 |
| Completion date | Dec. 31, 2018 |
| Required reporting date | Dec. 31, 2019, midnight |
| Actual reporting date | Nov. 5, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 675 |